Gaul G B
2nd Department of Internal Medicine, Hanusch-Krankenhaus, Vienna, Austria.
Thromb Haemost. 1999 Sep;82 Suppl 1:157-9.
The possibility of lysing clots by the direct intravascular application of ultrasound was described first in 1974 in an animal experiment. However research on therapeutic ultrasound for thrombolysis gained momentum in the early 1980s and is now divided into several directions: 1) pharmacological thrombolysis supported by externally applied ultrasound; 2) pharmacological thrombolysis accelerated by intravascular ultrasound; 3) lysis of intravascular clots by intravascular ultrasound applied as singular treatment; 4) facilitating angioplasty by intravascular ultrasound which may smoothen the rigid surface of calcified arteries by lysing calcified structures out of sclerotic plaques. In acute myocardial infarction first evidence of efficacy in lysing clots by ultrasound was described in two small series of 15 patients in 1997. Furthermore, ultrasound thrombolysis seems to be efficient also in occluded saphenous vein grafts and in completely obstructed peripheral arteries, where the latest clinical experience gives very promising results.
1974年在一项动物实验中首次描述了通过血管内直接应用超声溶解血栓的可能性。然而,用于溶栓的治疗性超声研究在20世纪80年代初获得了发展动力,目前分为几个方向:1)外部应用超声辅助的药物溶栓;2)血管内超声加速的药物溶栓;3)单独应用血管内超声溶解血管内血栓;4)血管内超声辅助血管成形术,通过溶解硬化斑块中的钙化结构来使钙化动脉的坚硬表面变平滑。在急性心肌梗死中,1997年在两个各有15例患者的小系列研究中描述了超声溶解血栓有效性的首个证据。此外,超声溶栓在隐静脉移植血管闭塞和完全阻塞的外周动脉中似乎也有效,最新的临床经验给出了非常有前景的结果。